Meeting
2013 Gastrointestinal Cancers Symposium
Prediction of clinical outcome in stage II and III colon cancer by a common gene variant in AXIN2.
Authors
Joanna Szkandera
Division of Oncology, Medical University of Graz
Joanna Szkandera , Gudrun Absenger , Melanie Weissmueller , Martin Pichler , Michael Stotz , Sigurd Lax , Gerhard Leitner , Martin Asslaber , Wilfried Renner , Armin Gerger
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 31, 2013 (suppl 4; abstr387)
DOI
10.1200/jco.2013.31.4_suppl.387
Abstract #
387
Poster Bd #
A55
Abstract Disclosures
Similar Posters
Poster
2012 Gastrointestinal Cancers Symposium
Evaluation of the prognostic value of guanylyl cyclase C (GCC) lymph node (LN) classification in patients with stage II colon cancer: A pooled analysis.
First Author: Daniel J. Sargent
Poster
2023 ASCO Annual Meeting
A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004.
First Author: Rona Yaeger
Poster
2020 Gastrointestinal Cancers Symposium
Polymorphisms of genes encoding for regulatory proteins in the coagulation cascade to predict outcome for stage II and III colon cancer.
First Author: Martin D. Berger
Poster
2018 Gastrointestinal Cancers Symposium
Association of genetic variations within the PD-L2 immune checkpoint gene with outcome in stage II and III colon cancer.
First Author: Martin D. Berger